{"record":{"author":{"account_ref":null,"orcid":null},"builds_on":[],"content_schema":"pubphys.content.topic/1","content_sha256":"3d00ddb5180beef94a893ad6ba5259c2e0494fc1f8079ec7ce7dbe5f8c33b8f6","created":"2026-10-03T07:17:52Z","files":[],"origin":{"assisted_by":[],"kind":"seed"},"parents":[],"salt":"cb1a3b7c07d74a22c6a9081d3027ab4c85a02de4ac54cd4a9112fbdf7d3506fb","schema":"pubphys.record/2","site":"pubphys.com","target":null,"type":"topic"},"content":{"external_id":"med.bnct","field":"med","n":"1","review_cite":"Suzuki, Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era, International Journal of Clinical Oncology, 2020","review_link":"https://doi.org/10.1007/s10147-019-01480-4","review_verified":"true","summary":"A drug carrying boron is loaded into tumour cells, and the patient is then exposed to slow neutrons, which split boron nuclei into two short-range charged fragments that destroy only the cell they are in. The difficulty is knowing how much boron is where, and what dose the mixed radiation actually delivers.","title":"Boron neutron capture therapy physics","topic_ref":null,"why":"The method targets individual cells rather than volumes, but its dose is currently estimated from blood boron levels and assumed ratios rather than measured in the tumour."},"attested":{"attestation":{"batch":null,"client_id":null,"id_token_sha256":null,"kind":"platform"},"record_hash":"0c8039c980b31f825989ca36e1cd7529f5aab83d616e66638b0e9746fc03ac15","schema":"pubphys.attested/1"},"envelope":{"attested_hash":"798594d74fd02f1f430228318c326bc0e1b5d5005483f8ced40f81ef15924122","platform_signature":{"key_id":"c6afc19b31429869751f06879c75cd64ea92654423d15b44be775bf1310a60da","sig":"kpdx-dGstxi-AlFkSviQwURQmPcCeth2Ahehgrv-bgBI9vp8nROGoBfeucmDX4c7JuRh-5MUhTnXI7-pFWX9DQ"},"schema":"pubphys.envelope/1"},"record_hash":"0c8039c980b31f825989ca36e1cd7529f5aab83d616e66638b0e9746fc03ac15","leaf_index":268}